St. Eriks Eye Hospital

St. Eriks Eye Hospital is a leading specialized ophthalmic center located in Stockholm, Sweden, and serves as one of Europe's most comprehensive providers of eye care. Owned by Region Stockholm and closely integrated with the Karolinska Institutet, the hospital functions as a major hub for clinical treatment, research, and medical education. It provides a full spectrum of services, from routine vision care to highly specialized surgical interventions for complex conditions such as retinal disorders, glaucoma, and corneal transplants. St. Eriks is a pioneer in translational research, notably leading clinical trials for stem cell-derived therapies and gene therapies aimed at treating previously incurable forms of blindness. The hospital recently relocated to the Hagastaden life science district to further enhance its collaborative research and development capabilities.